Marketing Strategy, Tactical Plan, and Growth Engine of BrightInsight Company

BrightInsight Company
Name
Department, Institution Affiliation
Course Code; Course Name
Instructor’s Name
Date
BrightInsight Company Analysis
BrightInsight is a United States startup that provides expert Biopharma and MedTech monitory services by employing technology to boost medical solutions. The organization’s medical-grade internet of things (IoT) program is created under a quality management system to promote and polish regulated drugs and software through incorporated information and actionable insights that enable clients to increase patients adherence and engagement. The platform expedites marketing time for pharmaceutical and medical technology organizations, decreases implementation and maintenance costs, and regulates global markets (BrightInsight, 2022a). The increased number of baby boomers in the United States presents a special challenge for the need to introduce medical services for individuals living a digital life. As a result, innovative care delivery influences new digital health technologies.
BrightInsight integrates data from integrated medical facilities and therapeutics to provide intelligence to pharmaceuticals and medical technology organizations. BrightInsight differs from other programs in the market supporting non-regulated medical facilities since it was created from the ground up to promote CE-marked and combination product necessities. Also, it promotes FDA-regulated grade I, II, and III medical devices. The regulations enable the company not only to data collection from multiple interconnected medical devices and modern therapeutics but also allow clients to run intelligence and analytics that can facilitate automated intervention for patients (Tamtoro, 2019). The main objective of using personalized healthcare is to improve patients’ results. BrightInsight allows customers to ingest huge data from IoT medical instruments, store crucial data, and process and apply logic in the data. Pharmaceuticals and medical technology organizations maximize their therapies to increase adherence and engagement through advanced analytics and machine learning facilities.
Pharmaceuticals and medical organizations can use BrightInsight platforms to capture intelligence from applications and connected medical facilities to enhance results and adherence for patients with chronic infections. For instance, COPD patients get connected inhalers with certain instructions, and doctors can monitor their compliance. BrightInsight program gathers information from connected inhalers. It provides insight into the inhaler usage that pharmaceutical enterprises can use to enhance the products while healthcare providers support the correct use by patients (Tamtoro, 2019). With inhalers, physicians might like to know the number of times a patient uses the inhaler and the inhalation duration to determine personalized usage instructions and improve patients’ results. BrightInsight clients work in highly governed industries, making security, privacy, and reliability substantial. The organization is bound to look for strengths in any partner willing to cooperate with them.
The regulatory procedures governing the medical sector are strict since FDA regulates the United States medical facilities. The regulations cover multiple aspects such as development procedures, risk management, and other aspects that must meet the required expectations to provide effective and safe products. Also, any technology applied by creators must undergo compliance evaluation to ensure that the capacities stipulated by vendors meet the standards and FDA requirements. Cyber security and data security are important concepts for Bright Insight customers and must adhere to strict HIPPA and GDPR requirements for patients’ data protection.
Marketing Strategy
The marketing strategy at Bright Insight is partnership marketing, where the company collaborates with other businesses to achieve its objectives. The company partners with enterprises with similar objectives and audiences and those that provide complimentary products or services. For instance, the company signed a deal with AstraZeneca (AZ) to create a digital health product to help individuals with chronic infections manage their conditions. The partnership allowed AstraZeneca to access BrightInsights IoT based in San Jose to develop applications, software, and interconnected devices to deliver patients better and more personalized care. The organization concentrates on biopharma and medical instruments, which must follow strict privacy, security, and governing rules when creating digital products. The partnership promoted digital health, and the company believes it can reduce major concerns in modern healthcare, such as the length and cost of clinical trials, improved remote testing, better tracking of patients, and better access to information (Taylor, 2020). Also, the partnership was an effective program for AstraZeneca since it allowed them to focus on digital health products without building technical underpinnings. The pre-built platform allowed them to speed up their marketing time while focusing on digital health inventions.
Additionally, BrightInsight collaborated with UCB to create and market a digital infection management plan for people with rare infections. BrightInsight program enabled UCB to develop and initiate its digital health while complying with privacy, security, and governing requirements worldwide (Pennic, 2022). On the flip side, UCB’s digital infection management explication would incorporate a mobile patient application to support individuals with Myasthenia Gravis, an infection that disrupts the nerves’ communication with muscles. Lastly, BrightInsight collaborated with Sanofi to market the advanced digital partner application for one of the products provided by Sanofi. BrightInsight program was selected to serve as a fundamental infrastructure to speed up continuous developments of Sanofi software as a m...